Continuous glucose monitoring has revolutionized diabetes management.
The devices, which are usually stuck to a person’s arm, stomach, or thigh, utilize a small sensor placed under the skin to
check blood sugar levels. This has freed people living with diabetes or those who are prediabetic from having to regularly prick and test blood from their fingers. It also allows for better control of blood sugar levels.
The technology has evolved since its inception in the 2000s and has been adopted by both type-1 and type-2 diabetes patients. And the potential growth
presents opportunities across the industry. The global market, which hit $6 billion in 2021, is expected to reach $31 billion by 2031, with a 17% compound annual growth rate.
Key players in the market like Abbott Laboratories, and Medtronic, have made substantial investments in research
and development to enhance the accuracy, performance, and comfort of their products. Studies
indicate that broader use of continuous glucose monitoring can lead to improved disease management and cut down overall healthcare expenses.
Now, the industry is on the cusp of another breakthrough — the use of non-invasive